临床肿瘤学杂志

• 论著 •    下一篇

siRNA靶向抑制CDCA5基因表达对人肝癌HepG2细胞增殖及凋亡的影响

陈墅圳,聂玉强,杜艳蕾,徐 言,沈桂佳   

  1. 510180 广州广州医科大学附属广州市第一人民医院消化内科 广州市消化病重点实验室
  • 收稿日期:2013-11-01 修回日期:2013-11-22 出版日期:2014-02-28 发布日期:2014-02-28
  • 通讯作者: 聂玉强

Influence of CDCA5-siRNA on proliferation and apoptosis of human hepatocarcinoma cell line HepG2

CHEN Shuzhen, NIE Yuqiang, DU Yanlei, XU Yan, SHEN Guijia.   

  1. Department of Gastroenterology,Guangzhou Key Laboratory of Digestive Disease,Guangzhou First Peoples Hospital,Guangzhou Medical University,Guangzhou 510180,China
  • Received:2013-11-01 Revised:2013-11-22 Online:2014-02-28 Published:2014-02-28
  • Contact: NIE Yuqiang

摘要:

目的 探讨小干扰RNA(siRNA)靶向抑制细胞分裂周期相关蛋白5(CDCA5)基因表达对人肝癌HepG2细胞株增殖及凋亡的影响。方法 优化siRNA转染条件,将3条靶向抑制CDCA5基因的siRNA载体片段(序列1、2和3)分别高效转染人肝癌HepG2细胞(A、B和C组),并设阴性对照组(NC组)及空白组。免疫印迹法检测转染72h各组CDCA5蛋白的表达水平。CCK-8法检测转染24、48、72、96、120h各组细胞的增殖能力,Annexin V-FITC/PI 双标记流式细胞术检测各组转染48h的凋亡情况。结果 A、B和C组的CDCA5蛋白水平均低于NC组和空白组(P<0.05),其中B组的表达率最低,抑制率最高,达89.3%,故选择序列2进行后续实验。自转染48h起,B组的相对增殖率均低于NC组和空白组(P<0.05);B组转染72h的相对增殖率为(66.58±2.58)%,均低于其他观察时间点(P<0.05)。B组转染48h的早期和晚期凋亡率分别为(17.43±2.31)%和(22.37±2.21)%,均高于NC组和空白组(P<0.05)。 结论 通过siRNA能够降低HepG2细胞的CDCA5表达水平,有效抑制HepG2细胞的增殖并促进其凋亡。

Abstract:

Objective To investigate influence of CDCA5 small interfering RNA(CDCA5-siRNA) on proliferation and apoptosis of human hepatocarcinoma cell line HepG2. Methods The HepG2 cells were divided into siRNA groups (A, B and C groups), universal scrambled negative control siRNA group (NC group)and Blank group. Three CDCA5siRNAs with different sequences were transfected into HepG2 cells respectively. Western blotting method was used to measure expressions of CDCA5 protein levels at 72h after transfection. The cell proliferation was assessed by CCK-8 at 24, 48, 72, 96 and 120h after transfection. The Annexin V-FITC/PI double-labeled flow cytometry was employed to measure the apoptosis at 48h after transfection.
Results The expressions of CDCA5 protein significantly decreased in the
CDCA5-siRNA groups (A,B and C groups) compared with NC group and Blank group(P<0.05). Group B had the lowest expression rate and highest inhibition rate(89.3%). The relative proliferation rate of group B was significantly lower than those of NC group and Blank group since 48 hours after transfection(P<0.05), and the lowest proliferation rate was (66.58±2.58)% at 72h in group B. The early and late apoptosis rates were (17.43±2.31) % and (22.37±2.21) % in B group, higher than those of other two groups(P<0.05). Conclusion siRNA down-regulating the expression of CDCA5 gene in human hepatocarcinoma cell line HepG2 can inhibit cell proliferation and increase cell apoptosis.

No related articles found!
Viewed
Full text


Abstract

Cited

  Shared   
  Discussed   
No Suggested Reading articles found!